Navigating the Challenges in Recognizing and Managing Psychiatric Disorders for Primary Care Practitioners

Sponsored for CME credit by Rush University Medical Center.

Presented by the University of Tennessee College of Pharmacy.

This activity is funded by an unrestricted educational grant from Alkermes.

Mental illness is a leading cause of morbidity in the United States, and the economic and social burden of disease is despairingly high. The large majority of patients with disorders such as depression, bipolar disorder, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, and schizophrenia are diagnosed and treated in primary care settings. Thus, primary care practitioners (PCPs), including physicians, nurse practitioners, physician assistants, and pharmacists, must provide care themselves to patients with psychiatric illnesses while directing those with more complex or heterogeneous diagnoses to mental health specialists. Mental healthcare delivered by a PCP has the potential to circumnavigate a number of well-established treatment limitations: it is more accessible, less stigmatizing, and more comprehensive. Nevertheless, primary-care–based management of patients with mental illness has proven unsatisfactory due to patients’ lack of awareness about the nature of mental disorders, limited access to physicians, and insurance and payment barriers. More importantly, many PCPs have not been properly trained to treat patients with these disorders, and others lack confidence in their ability to care for this population. As a result, patients with psychiatric conditions are undiagnosed or inadequately treated, inappropriate psychotropic drugs are prescribed with little follow-up, and overall physical and mental health outcomes are poor. Overcoming the challenges facing PCPs in managing patients with mental illnesses in the community is the focus of this educational initiative. Participants will review a description of the most commonly seen mental disorders, review various drug classes and options for treatment (pharmacologic and nonpharmacologic), assess the barriers to care and ways to overcome them, as well as the clinical role of the PCP in working collaboratively with specialists.

This educational activity will enable PCPs to identify the common signs and symptoms of patients with psychiatric disorders, select appropriate pharmacologic and psychosocial treatments, discuss practical treatment strategies with specialists, and explain the benefits and risks of pharmacologic treatments with patients, family members, and caregivers.

This activity is intended for primary care physicians, nurse practitioners, physicians’ assistants, nurses, and community pharmacists. No prerequisites required.

The University of Tennessee College of Pharmacy takes responsibility for the content, quality, and scientific integrity of this CPE activity. At the conclusion of this activity, the participant should be able to:
  • IDENTIFY signs and symptoms seen in common psychiatric disorders.
  • SELECT appropriate treatments based on disease state and individual patient needs.
  • DISCUSS practical strategies for the treatment of psychiatric disorders that empower primary care providers to initiate treatment and/or referral in a timely manner.
  • EXPLAIN the benefits and risks of available pharmacologic treatment options.
Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing education for the healthcare team.

Rush University Medical Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ANCC Credit Designation – Nurses
The maximum number of hours awarded for this CE activity is 1.0 contact hour.

This activity is being presented without bias and with commercial support.

The University of Tennessee College of Pharmacy is accredited by the Accreditation Council for Pharmacy acpe logoEducation (ACPE) as a provider of continuing pharmacy education. Successful completion of this application-based program will provide a statement for 1.0 contact hour of credit (0.10 CEU) and will be available at the completion of the activity. Successfully completing the activity and receiving credit includes: 1) reading the learning objectives and faculty disclosures; 2) studying the educational activity; 3) evaluating the activity; and, 4) completing the self-assessment instrument with a score of at least 70%. UAN: 0064-0000-16-220-H01-P. CE credit will be submitted to the NABP CPE Monitor within 30 days. It is recommended that you check your NABP CPE Monitor e-profile database 30 days after the completion of any CE activity to ensure that your credits are posted.

Pharmacists or pharmacy technicians with questions regarding their NABP e-Profile or CPE Monitor should refer to the FAQ section on the NABP website: To receive credit for your participation in this activity, all pharmacists must include their NABP e-Profile ID number, along with their month and day of birth. If incorrect information is provided, this will result in "rejected" status from the CPE Monitor. It is the responsibility of the participant to notify The University of Tennessee (within the 60 day submission timeframe) of their corrected information. Otherwise, the completed CE will not be accepted by the CPE Monitor.
Please allow up to 30 days for your credit to appear on CPE Monitor.

The estimated time to complete this activity: 1.0 hour.

Release date: November 18, 2016         Expiration date: November 18, 2017

As an accredited provider by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of The University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Director and Participating Faculty reported the following:

Charles Hebert, MD (Chair/Author)
Assistant Professor
Department of Psychiatry, Rush Medical College
Director, Psychiatric Consultation Service
Hospitalist, Department of Internal Medicine
Assistant Professor, Department of Internal Medicine
Chicago, Illinois
Dr Hebert reports having no relevant financial or advisory relationships with corporate organizations related to this activity.

The course directors, planners and faculty of this activity have no relevant financial relationships to disclose.

All other individuals in control of content have stated they have no relevant financial disclosures.

In accordance with requirements of the FDA, the audience is advised that information presented in this continuing medical education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA approved package insert for each drug/device for full prescribing/utilization information. It is the policy of the Rush University Office of Interprofessional Continuing Education to ensure that its CE activities are independent, free of commercial bias and beyond the control of persons or organizations with an economic interest in influencing the content of CE. Everyone who is in a position to control the content of an educational activity must disclose all relevant financial relationships with any commercial interest (including but not limited to pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic) within the preceding 12 months.

In accordance with ACPE Criteria for Quality, the audience is advised that authors in this CPE activity may include reference(s) to unlabeled, unapproved, or investigational uses of therapeutic agents or biomedical devices. The authors will inform the reader of when they discuss or reference an unapproved, unlabeled, or investigational use of therapeutic agent or biomedical device.

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This activity is produced for educational purposes only. Use of The University of Tennessee College of Pharmacy name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings, and adverse effects, before administering pharmacologic therapy to patients.

A participant, provider, faculty member, or other individual wanting to file a grievance with respect to any aspect of an activity provided or coprovided by The University of Tennessee College of Pharmacy may contact the Associate Dean for Continuing Education in writing at The grievance will be reviewed and a response will be returned within 45 days of receiving the written statement. If not satisfied, an appeal to the Dean of the College of Pharmacy can be made for a second level review.

There is no fee for this educational activity.

The following is an interactive case simulation designed to help you gauge your basic knowledge of the topic and then direct you to areas you may need to focus on. It consists of 3 sections: an unaccredited pre-assessment, an interactive case study, and a CPE post-assessment and evaluation. All 3 sections must be completed to receive CPE credit. A statement of credit will be available online immediately following successful completion of the activity.


Navigating the Challenges in Recognizing and Managing Psychiatric Disorders for Primary Care Practitioners
Charles Hebert, MD


Submit a case to review at meeting:

procced to pretest

MyCMESite is published by ASiM CE, LLC, d/b/a ASiM 166 W. Main Street, Somerville, NJ 08876. (908) 253-9001. Copyright ©2017 by ASiM CE, LLC. All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from the publisher. ASiM is a registered trademark of ASiM CE LLC. Contact Us